Down Syndrome Research Today is a free monthly online journal that collates and summarizes the latest research about Down Syndrome, including details on education, symptoms, treatment, information.

Volume 1 (2004), Issue 3 (November)

1. Minocycline prevents cholinergic loss in a mouse model of Down's syndrome.
   Ann Neurol, 56(5): 675-88. [Abstract] [Full-text]
2. Ocular coloboma and high myopia with Hirschsprung disease associated with a novel ZFHX1B missense mutation and trisomy 21.
   Am J Med Genet A, 131(1): 86-90. [Abstract] [Full-text]
3. Functional analysis of genes implicated in Down syndrome: 1. Cognitive abilities in mice transpolygenic for Down Syndrome Chromosomal Region-1 (DCR-1).
   Behav Genet, 34(6): 559-69. [Abstract] [Full-text]
4. First- and midtrimester Down syndrome screening and detection.
   Clin Perinatol, 31(4): 677-94, v. [Abstract] [Full-text]
5. Down's syndrome astrocytes have greater antioxidant capacity than euploid astrocytes.
   Eur J Neurosci, 20(9): 2355-66. [Abstract] [Full-text]
6. Synaptic structural abnormalities in the Ts65Dn mouse model of Down Syndrome.
   J Comp Neurol, 480(3): 281-98. [Abstract] [Full-text]
7. Specificity and sensitivity of S100B levels in amniotic fluid for Down syndrome diagnosis.
   Life Sci, 76(4): 379-84. [Abstract] [Full-text]
8. Down syndrome with morgagni hernia and hypothyroidism.
   J Coll Physicians Surg Pak, 14(11): 689-90. [Abstract] [Full-text]
9. Prenatal diagnosis of common aneuploidies using multiplex quantitative fluorescent polymerase chain reaction.
   Fetal Diagn Ther, 19(6): 496-503. [Abstract] [Full-text]
10. Cephalic index is not a useful sonographic marker for trisomy 21 and trisomy 18.
    Fetal Diagn Ther, 19(6): 491-5. [Abstract] [Full-text]
11. Biochemical screening for congenital defects.
    Obstet Gynecol Clin North Am, 31(4): 857-72, xi. [Abstract] [Full-text]
12. Between 'desperation' and disability rights: a narrative analysis of complementary/alternative medicine use by parents for children with Down syndrome.
    Soc Sci Med, 60(3): 587-98. [Abstract] [Full-text]
13. Pregnancy outcomes in unselected singleton pregnant women with an increased risk of first-trimester Down's syndrome.
    Acta Obstet Gynecol Scand, 83(12): 1130-4. [Abstract] [Full-text]
14. Communicating with pediatricians about complementary/alternative medicine: perspectives from parents of children with down syndrome.
    Ambul Pediatr, 4(6): 488-94. [Abstract] [Full-text]
15. Stepping over obstacles: anticipatory modifications in children with and without Down syndrome.
    Exp Brain Res, 159(4): 487-90. [Abstract] [Full-text]
16. Childhood and maternal infections and risk of acute leukaemia in children with Down syndrome: a report from the Children's Oncology Group.
    Br J Cancer, 91(11): 1866-72. [Abstract] [Full-text]
17. Transient leukemia in newborns with Down syndrome.
    Pediatr Blood Cancer, 44(1): 29-32. [Abstract] [Full-text]
18. Acute myeloid leukemia and Down syndrome evolution of modern therapy--state of the art review.
    Pediatr Blood Cancer, 44(1): 13-20. [Abstract] [Full-text]
19. GATA1 mutations in Down syndrome: implications for biology and diagnosis of children with transient myeloproliferative disorder and acute megakaryoblastic leukemia.
    Pediatr Blood Cancer, 44(1): 40-4. [Abstract] [Full-text]
20. Down syndrome, drug metabolism and chromosome 21.
    Pediatr Blood Cancer, 44(1): 33-9. [Abstract] [Full-text]
21. Tetrasomy 21 transient leukemia with a GATA1 mutation in a phenotypically normal trisomy 21 mosaic infant: case report and review of the literature.
    Pediatr Blood Cancer, 44(1): 85-91. [Abstract] [Full-text]
22. Epidemiology of leukemia in children with Down syndrome.
    Pediatr Blood Cancer, 44(1): 8-12. [Abstract] [Full-text]
23. Lymphoblast biology and outcome among children with Down syndrome and ALL treated on CCG-1952.
    Pediatr Blood Cancer, 44(1): 21-8. [Abstract] [Full-text]
24. Misdiagnosis of thyroid disorders in down syndrome: time to re-examine the myth?
    Am J Ment Retard, 110(1): 23-7. [Abstract] [Full-text]
25. Blood expression profiles for tuberous sclerosis complex 2, neurofibromatosis type 1, and Down's syndrome.
    Ann Neurol, 56(6): 808-14. [Abstract] [Full-text]

© 2004-2008 Down Syndrome Research Today. All Rights Reserved.